The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.
Jennifer Scarlet HaasKim-Sarah KrinkeChristopher MaasThomas HardtIsabella BarckSebastian BraunPublished in: BMC nephrology (2020)
The disease burden was higher for patients with HK, based on a higher proportion of patients with dialysis initiation and higher healthcare costs.